We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$47.6M
AUM Growth
-$41.5B
Cap. Flow
+$3.17B
Cap. Flow %
6,658.61%
Top 10 Hldgs %
20.94%
Holding
3,928
New
227
Increased
1,971
Reduced
1,419
Closed
152

Sector Composition

Rank Sector Weight
1 Technology 10.27%
2 Communication Services 7.27%
3 Financials 4.98%
4 Healthcare 4.53%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UP icon
3651
Wheels Up
UP
$220M
$25 ﹤0.01%
200
+10
+5% +$2.22K
ABSI icon
3652
Absci
ABSI
$1.28B
$24 ﹤0.01%
14,000
-15,500
-53% -$37.5K
AQB icon
3653
AquaBounty Technologies
AQB
$4.68M
$24 ﹤0.01%
2,082
+575
+38% +$9.25K
TRML
3654
DELISTED
Tourmaline Bio
TRML
$24 ﹤0.01%
1,300
HLTH
3655
DELISTED
Cue Health Inc. Common Stock
HLTH
$24 ﹤0.01%
13,354
-896
-6% -$1.95K
ELBM
3656
Electra Battery Materials
ELBM
$53.9M
$23 ﹤0.01%
2,867
CELU icon
3657
Celularity
CELU
$21.7M
$22 ﹤0.01%
3,572
+50
+1% +$402
TNXP icon
3658
Tonix Pharmaceuticals
TNXP
$157M
$22 ﹤0.01%
2
THCX
3659
DELISTED
AXS Cannabis ETF
THCX
$22 ﹤0.01%
1,047
-1,517
-59% -$38K
AQMS icon
3660
Aqua Metals
AQMS
$9.63M
$21 ﹤0.01%
107
-219
-67% -$51.2K
EM
3661
DELISTED
Smart Share Global Ltd
EM
$21 ﹤0.01%
19,365
INO icon
3662
Inovio Pharmaceuticals
INO
$79.8M
$21 ﹤0.01%
2,164
-102
-5% -$1.74K
UROY
3663
Uranium Royalty Corp
UROY
$434M
$21 ﹤0.01%
10,361
LLAP
3664
DELISTED
Terran Orbital Corporation
LLAP
$21 ﹤0.01%
+11,600
New +$22.4K
DMRA
3665
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.77B
$20 ﹤0.01%
407
PLG
3666
Platinum Group Metals
PLG
$164M
$20 ﹤0.01%
14,339
PXLW icon
3667
Pixelworks
PXLW
$38.8M
$20 ﹤0.01%
1,142
+250
+28% +$5.26K
SEEL
3668
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$20 ﹤0.01%
8
FRZA
3669
DELISTED
Forza X1, Inc. Common Stock
FRZA
$20 ﹤0.01%
17,000
+3,000
+21% +$4.22K
ADCT icon
3670
ADC Therapeutics
ADCT
$146M
$19 ﹤0.01%
+10,093
New +$37.2K
BDSX icon
3671
Biodesix
BDSX
$228M
$19 ﹤0.01%
+529
New +$21.7K
MBIO icon
3672
Mustang Bio
MBIO
$4.26M
$19 ﹤0.01%
71
+7
+11% +$2.87K
RGS icon
3673
Regis Corp
RGS
$69.9M
$19 ﹤0.01%
+900
New +$24.9K
SCOR icon
3674
Comscore
SCOR
$19 ﹤0.01%
798
XFOR icon
3675
X4 Pharmaceuticals
XFOR
$363M
$19 ﹤0.01%
750

Similar funds

Commonwealth Equity Services's Q1 2023 Portfolio in Review

As of Q1 2023, Commonwealth Equity Services held 3,928 positions worth $47.6M, down 100% from $41.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Commonwealth Equity Services deployed $3.17B of net new capital in Q1 2023, opening 227 new positions and adding to 1,971 existing holdings. Its largest new stake was GE HealthCare: 100,791 shares worth $8.27K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.3% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was iShares ESG Aware MSCI USA ETF, an estimated $31.4M trimmed.

  • Commonwealth Equity Services's largest Q1 2023 buy was GE HealthCare: 100,791 shares worth $8.27K.
  • Commonwealth Equity Services added most to Chevron in Q1 2023, an estimated $1.73B increase.
  • Commonwealth Equity Services's biggest Q1 2023 reduction was iShares ESG Aware MSCI USA ETF, cutting an estimated $31.4M.
  • Commonwealth Equity Services fully exited FT Vest Gold Strategy Quarterly Buffer ETF in Q1 2023, selling an estimated $4.08M.
  • Commonwealth Equity Services's ten largest holdings make up 21% of its $47.6M portfolio in Q1 2023.
  • Commonwealth Equity Services opened 227 new positions and closed 152 in Q1 2023.
  • Commonwealth Equity Services's portfolio value fell 100% quarter-over-quarter to $47.6M.

Based on Commonwealth Equity Services's 13F filing for Q1 2023, filed 11 May 2023.